Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

SHL Telemedicine stock

SHLTN.SW
IL0010855885
589969

Price

2.66
Today +/-
-0.22
Today %
-8.62 %
P

SHL Telemedicine stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the SHL Telemedicine stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the SHL Telemedicine stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the SHL Telemedicine stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze SHL Telemedicine's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

SHL Telemedicine Stock Price History

DateSHL Telemedicine Price
11/1/20242.66 undefined
10/31/20242.90 undefined
10/30/20242.89 undefined
10/29/20242.64 undefined
10/25/20242.88 undefined
10/24/20242.88 undefined
10/23/20242.89 undefined
10/22/20242.89 undefined
10/21/20242.86 undefined
10/18/20242.86 undefined
10/17/20242.86 undefined
10/16/20242.86 undefined
10/15/20242.78 undefined
10/14/20242.86 undefined
10/11/20242.88 undefined
10/10/20242.88 undefined
10/9/20242.69 undefined
10/8/20242.89 undefined
10/7/20242.93 undefined

SHL Telemedicine Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into SHL Telemedicine, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by SHL Telemedicine from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects SHL Telemedicine’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of SHL Telemedicine. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into SHL Telemedicine’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing SHL Telemedicine’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on SHL Telemedicine’s growth potential.

SHL Telemedicine Revenue, EBIT and net profit per share

DateSHL Telemedicine RevenueSHL Telemedicine EBITSHL Telemedicine Net Income
202357.08 M undefined-7.77 M undefined-7.06 M undefined
202259 M undefined-5.17 M undefined-76,000 undefined
202149.58 M undefined211,000 undefined-14.11 M undefined
202040.16 M undefined444,000 undefined278,000 undefined
201941.88 M undefined5.44 M undefined5.7 M undefined
201848.86 M undefined11.74 M undefined10.14 M undefined
201737.38 M undefined1.2 M undefined2.41 M undefined
201640.55 M undefined-986,000 undefined-11.1 M undefined
201537.09 M undefined-8.4 M undefined-15.74 M undefined
201439.98 M undefined1.29 M undefined829,000 undefined
201329.7 M undefined3.1 M undefined2.2 M undefined
201226.9 M undefined-5.7 M undefined-7.3 M undefined
201142.4 M undefined4.2 M undefined4 M undefined
201050.3 M undefined6 M undefined4.9 M undefined
200947.9 M undefined6.7 M undefined5.4 M undefined
200844.6 M undefined4.2 M undefined2.2 M undefined
200762.1 M undefined-10.1 M undefined23.4 M undefined
200683.2 M undefined5 M undefined-8.5 M undefined
200599 M undefined-4.1 M undefined-9.2 M undefined
2004103.1 M undefined-1.7 M undefined-6.1 M undefined

SHL Telemedicine Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
14151930899810399836244475042262939374037484140495857
-7.1426.6757.89196.6710.115.10-3.88-16.16-25.30-29.036.826.38-16.00-38.1011.5434.48-5.138.11-7.5029.73-14.58-2.4422.5018.37-1.72
50.0053.3357.8966.6750.5646.9442.7244.4448.1959.6870.4572.3470.0069.0553.8551.7256.4143.2452.5051.3562.5056.1050.0048.9846.5543.86
78112045464444403731343529141522162119302320242725
1149113-1-45-104664-531-80111500-5-7
7.146.6721.0530.0012.363.06-0.97-4.046.02-16.139.0912.7712.009.52-19.2310.342.56-21.62-2.7022.9212.20---8.62-12.28
-101121-10-6-9-8232544-720-15-1121050-140-7
---1,100.00-91.67-1,100.00-40.0050.00-11.11-387.50-91.30150.00-20.00--275.00-128.57---26.67-118.18400.00-50.00----
5.65.66.610.710.610.610.610.710.610.810.610.510.610.510.510.510.4610.4810.4910.510.5210.510.514.0514.5416.27
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The SHL Telemedicine Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the SHL Telemedicine is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                 
0.163.460.251.826.122.12112.584.523.520.120.233.326.828.417.088.5610.5610.398.856.0810.6227.191522.09
1.414.123.623.223.920.718.81.72.86.36.29.79.510.415.267.089.765.426.55.664.928.128.188.98
6.15.35.810.78.57.80.80.72.71.82.62.81111.66.33.461.241.49.036.610.741.020.20.20.14
1.22.23.36.16.26.20.60.60.60.60.6000.40.92.482.772.392.211.31.141.374.23.883.46
1.31.62.45.611.24.22.74.72.12.121.91.71.61.81.270.730.80.760006.155.035.39
10.173.575.897.875.264.245.837.391.630.831.631.155.749.947.839.5620.3624.9127.8123.2613.6117.9445.8632.2940.06
1.62.32.711.412.416.324.823.715.615.317.11815.715.31612.657.545.524.953.5415.3415.2117.0415.6912.11
002.624.24.84.34.44.40.10.10.20.10.20.20.881.360.810.880.220.40.440.450.420.33
7.312.92332.736.433.23.33.23.42.83.912.95.62.400000000000
1.52.23.64.34.75.25475.117.36.77.68.49.419.116.2316.4310.399.346.955.674.6720.7920.4320.26
1.214.917.847.147.247.842011.401313.812.81314.112.4914.6515.261715.8216.8518.1737.5133.7532.97
6.8910.812.616.324.212.112.912.615.614.311.59.99.511.410.336.515.745.535.747.928.397.958.217.34
18.441.360.5110.1121.2131.591.591.252.551.155.16452.549.860.852.5746.4837.7237.732.2746.1946.8883.7378.4972.99
28.5114.8136.3207.9196.4195.7137.3128.5144.181.986.795.1108.299.7108.692.1366.8562.6365.555.5359.864.81129.59110.78113.05
                                                 
00000000000000031313131313131424348
1.79291.678.191.691.691.89292.392.792.993.493.994.39595.1995.3895.8695.9596.596.7396.74125.48130.01156.33
-4.1-2.99.210.60.4-5.7-44.7-54.9-31.5-33.3-27.9-23-26-33.3-31.1-30.31-55.81-66.91-64.5-54.36-59.17-58.89-73-73.07-80.13
2.22.6-5.71.9-5.4-5.2-7.2-7.8-0.111.55.80.82.16.5-1.53-3.61-2.970.16-2.15-0.72.274.41-1.29-2.72
000000000-0.10.30.100.71.400.660.23000.20000
-0.291.795.190.686.680.739.929.360.760.366.876.368.763.871.863.3836.6426.2431.6440.0337.0940.1556.9455.6973.53
1.21.626.27.58.68.4821.52.2211.21.40.981.021.140.961.081.121.632.893.763.88
0.20.51.586.94.33.600005.34.74.24.65.087.636.9815.9911.14006.927.057.37
1.51.73.89.26.410.15.91023.216.217.69.73.42.62.80.071.833.653.063.169.838.923.422.591.59
0000.20.10000000006.96.946.967.074.140.9302.33000
8.83.120.147.646.942.141.929.542.40.60.52.49.48.53.63.33.396.868.7801.321.624.144.434.6
11.76.927.471.267.865.159.847.567.618.320.319.418.516.519.316.3720.8225.6932.9216.3112.2714.517.3617.8317.44
16.415.512.642.638.843.232.644.47.600022.119.918.212.939.459.561.49010.9610.6228.3622.3115.26
0000.70.90.80.60.50.30.30.40.20.20001.080.780.690.520.370.243.432.72.31
0.40.51.11.51.45.13.568.14.10.60.80.82.42.11.431.32.781.21.021.461.5819.678.661.57
16.81613.744.841.149.136.750.9164.41123.122.320.314.3611.8213.123.371.5412.7812.4451.4733.6719.15
28.522.941.1116108.9114.296.598.483.622.721.320.441.638.839.630.7332.6538.8136.2917.8425.0626.9468.8351.4936.59
28.3114.6136.2206.6195.5194.9136.4127.7144.38388.196.7110.3102.6111.494.1169.2965.0667.9357.8762.1567.09125.77107.18110.12
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of SHL Telemedicine provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand SHL Telemedicine's financial health and stability.

Assets

SHL Telemedicine's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that SHL Telemedicine must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of SHL Telemedicine after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into SHL Telemedicine's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-101121-10-4-7-7272544-720-15-1121050-130
0012684788445444655433457
00000-5-1700-311000000000000
-1-4-7-19-1503009-12-5-8-1222-109-62-410-6-3
0002980-80-4810002-70511220014-3
0000564544100111000000001
0000211004010000001220011
-3-3-4-120101-1-753-312-330111210400
-1-1-1-3-4-5-6-6-6-5-5-6-5-4-4-4-4-2-1-1-1-1-1-3-6
-10-14-1-50-11413-5104-22-6-4-4-3-300-1-102-7-40-6
00-121-45-510201110-1701010530004-5-370
0000000000000000000000000
23-101532-7-4-8-4-22-520131-4-2-2-33-11-12-1013-4
207900000000000000000000371
43691431-10-6-10-6-27-570223-4-1-2-33-11-12-11051-2
------2.00-2.00-1.00-1.00-4.00---------------
0000000000-300-60000000-10000
00506-20-1802-974-81-1014-6-1-5110-11-110-10
-4.4-4.88-6-4.32-2.38-4.89-4.96-7.09-4.77-7.71-12.8-1.7-2.7-8.08-2.8-1.26-7.41.23-2.2410.2411.518.882.91-3.07-6.98
0000000000000000000000000

SHL Telemedicine stock margins

The SHL Telemedicine margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SHL Telemedicine. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SHL Telemedicine.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the SHL Telemedicine's sales revenue. A higher gross margin percentage indicates that the SHL Telemedicine retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the SHL Telemedicine's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the SHL Telemedicine's total revenue generated. When comparing the revenue margin year over year, investors can gauge the SHL Telemedicine's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the SHL Telemedicine. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the SHL Telemedicine's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

SHL Telemedicine Margin History

SHL Telemedicine Gross marginSHL Telemedicine Profit marginSHL Telemedicine EBIT marginSHL Telemedicine Profit margin
202344.26 %-13.62 %-12.36 %
202246.08 %-8.76 %-0.13 %
202149.6 %0.43 %-28.46 %
202051.4 %1.11 %0.69 %
201956.02 %12.99 %13.6 %
201861.83 %24.03 %20.75 %
201752.42 %3.21 %6.44 %
201651.96 %-2.43 %-27.37 %
201545.59 %-22.64 %-42.44 %
201455.69 %3.22 %2.07 %
201353.54 %10.44 %7.41 %
201253.16 %-21.19 %-27.14 %
201169.34 %9.91 %9.43 %
201070.78 %11.93 %9.74 %
200971.82 %13.99 %11.27 %
200871.3 %9.42 %4.93 %
200760.87 %-16.26 %37.68 %
200648.8 %6.01 %-10.22 %
200545.05 %-4.14 %-9.29 %
200443.36 %-1.65 %-5.92 %

SHL Telemedicine Stock Sales Revenue, EBIT, Earnings per Share

The SHL Telemedicine earnings per share therefore indicates how much revenue SHL Telemedicine has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SHL Telemedicine earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SHL Telemedicine's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SHL Telemedicine’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SHL Telemedicine's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SHL Telemedicine Revenue, EBIT and net profit per share

DateSHL Telemedicine Sales per ShareSHL Telemedicine EBIT per shareSHL Telemedicine Earnings per Share
20233.51 undefined-0.48 undefined-0.43 undefined
20224.06 undefined-0.36 undefined-0.01 undefined
20213.53 undefined0.02 undefined-1 undefined
20203.82 undefined0.04 undefined0.03 undefined
20193.99 undefined0.52 undefined0.54 undefined
20184.65 undefined1.12 undefined0.96 undefined
20173.56 undefined0.11 undefined0.23 undefined
20163.87 undefined-0.09 undefined-1.06 undefined
20153.54 undefined-0.8 undefined-1.5 undefined
20143.82 undefined0.12 undefined0.08 undefined
20132.83 undefined0.3 undefined0.21 undefined
20122.56 undefined-0.54 undefined-0.7 undefined
20114.04 undefined0.4 undefined0.38 undefined
20104.75 undefined0.57 undefined0.46 undefined
20094.56 undefined0.64 undefined0.51 undefined
20084.21 undefined0.4 undefined0.21 undefined
20075.75 undefined-0.94 undefined2.17 undefined
20067.85 undefined0.47 undefined-0.8 undefined
20059.25 undefined-0.38 undefined-0.86 undefined
20049.73 undefined-0.16 undefined-0.58 undefined

SHL Telemedicine business model

SHL Telemedicine Ltd is a leading company in the field of telemedicine solutions and was founded in Israel in 1987. The company develops, produces, and distributes medical equipment and software applications to offer remote monitoring services for various industries. The company started as a pioneer in the telemedicine industry, manufacturing devices for remote monitoring of high blood pressure and diabetes. Today, the company offers a wide range of telemedicine devices and solutions that allow patients and medical professionals to maintain control over their health and medical data. SHL Telemedicine operates on a global level and has expanded its presence in various advanced countries, including Europe, North America, and the Asia-Pacific region. The company has also had strategic partnerships with various international organizations and governments to spread its telemedicine solutions worldwide. Business Model: The company operates under a business-to-business model and provides a range of cost-effective and high-quality telemedicine solutions for various industries, including life sciences, health technology, financial services, government organizations, and insurance. SHL Telemedicine offers its customers products and services related to remote monitoring, tele-diagnosis, teleconsultation, and patient management. The company's solutions are versatile and aim to improve the quality of healthcare and reduce costs. Products and Services: The company offers a wide range of products and services aimed at improving healthcare and providing medical professionals, patients, and decision-makers with improved control over their health. Some of the company's most well-known products and services include: 1. CardioSTAT: A solution for remote monitoring of heart patients 2. DiabetesSTAT: A device for remote monitoring of diabetes patients 3. GraB: A device for monitoring and treating sleep disorders 4. Carenet: A platform for tele-diagnosis and teleconsultation 5. SHL Connect: A platform that allows patients to track their health data online 6. eXzellenZ: A platform that enables medical professionals and doctors to provide remote monitoring services SHL Telemedicine is committed to offering a comprehensive and flexible range of telemedicine products and services to improve healthcare worldwide. The company aims to enhance patients' quality of life, increase the efficiency of medical care, and promote cost savings in the healthcare industry. SHL Telemedicine is one of the most popular companies on Eulerpool.com.

SHL Telemedicine SWOT Analysis

Strengths

SHL Telemedicine Ltd has established itself as a leading provider of telemedicine services, offering convenient and accessible healthcare solutions.

The company has developed a robust technological platform, facilitating seamless integration with healthcare providers and patients.

SHL Telemedicine has a strong network of skilled healthcare professionals who deliver high-quality medical consultations remotely.

The company's telemedicine services have the potential to improve healthcare access in remote areas and reduce overcrowding in hospitals.

Weaknesses

SHL Telemedicine may face resistance from traditional healthcare providers who are skeptical about the effectiveness and security of telemedicine.

The company might experience challenges in gaining trust and acceptance from patients who prefer in-person consultations and are unfamiliar with telemedicine.

The effectiveness of telemedicine heavily relies on reliable internet connectivity, which can be a barrier in some regions.

Opportunities

The increasing adoption of digital technologies and the demand for convenient healthcare services present a significant growth opportunity for SHL Telemedicine.

The company can expand its services globally, targeting underserved regions with limited access to healthcare facilities.

Telemedicine has the potential to improve healthcare outcomes and reduce healthcare costs, making it an attractive option for insurance providers and government healthcare systems.

Threats

SHL Telemedicine faces competition from other telemedicine providers and traditional healthcare institutions that are also expanding their telemedicine offerings.

Changes in regulations and reimbursement policies may impact the financial viability of the telemedicine industry.

Data privacy and security concerns can pose a threat to the adoption of telemedicine services, leading to potential breaches and loss of patient trust.

SHL Telemedicine Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

SHL Telemedicine historical P/E ratio, EBIT multiple, and P/S ratio

SHL Telemedicine shares outstanding

The number of shares was SHL Telemedicine in 2023 — This indicates how many shares 16.269 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SHL Telemedicine earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SHL Telemedicine's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SHL Telemedicine’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SHL Telemedicine's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SHL Telemedicine dividend history and estimates

In 2023, SHL Telemedicine paid a dividend amounting to 0 USD. Dividend means that SHL Telemedicine distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for SHL Telemedicine provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify SHL Telemedicine’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating SHL Telemedicine's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

SHL Telemedicine Dividend History

DateSHL Telemedicine Dividend
20191 undefined
20110.66 undefined
20080.37 undefined

SHL Telemedicine dividend payout ratio

In 2023, SHL Telemedicine had a payout ratio of 183.62%. The payout ratio indicates the percentage of the company's profits that SHL Telemedicine distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for SHL Telemedicine represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for SHL Telemedicine could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate SHL Telemedicine's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

SHL Telemedicine Payout Ratio History

DateSHL Telemedicine Payout ratio
2023183.62 %
2022183.82 %
2021183.64 %
2020183.4 %
2019184.42 %
2018183.11 %
2017182.68 %
2016182.21 %
2015181.41 %
2014180.8 %
2013179.02 %
2012178.95 %
2011173.68 %
2010178.74 %
2009178.1 %
2008176.19 %
2007178.1 %
2006178.1 %
2005178.1 %
2004178.1 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for SHL Telemedicine.

Eulerpool ESG Scorecard© for the SHL Telemedicine stock

Eulerpool World ESG Rating (EESG©)

30/ 100

🌱 Environment

13

👫 Social

39

🏛️ Governance

38

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees61
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

SHL Telemedicine shareholders

%
Name
Stocks
Change
Date
36.41789 % Mengke (Cai) & Shen (Kun)5,969,41308/20/2023
14.02691 % Y.D More Investments Ltd2,299,2112,299,21112/31/2023
11.05776 % More Investment House Ltd.1,812,52508/20/2023
8.57909 % Value Base1,406,23602/8/2024
5.00125 % Sphera Funds Management Ltd.819,77608/20/2023
4.88948 % Alroy (Yariv)801,45608/20/2023
4.82816 % Danbar Holdings & Investments Ltd.791,40564,5122/8/2024
0.79022 % UBS Fund Management (Switzerland) AG129,52909/30/2024
0.74873 % Wulkan (Matan)122,72747,1942/8/2024
0.50073 % UBS Asset Management (Switzerland)82,07609/30/2024
1
2

SHL Telemedicine Executives and Management Board

Mr. Erez Nachtomy(62)
SHL Telemedicine Chief Executive Officer, Executive Director (since 2001)
Compensation 462,358
Mr. Yariv Alroy(63)
SHL Telemedicine Non-Executive Co-Chairman of the Board (since 2001)
Compensation 269,766
Mr. Yehoshua Abramovich
SHL Telemedicine Non-Executive Independent Director
Compensation 112,168
Mr. Ehud Barak(81)
SHL Telemedicine Non-Executive Co-Chairman of the Board (since 2022)
Compensation 69,939
Ms. Dvora Kimhi
SHL Telemedicine Non-Executive Independent Director
Compensation 48,477
1
2

SHL Telemedicine Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Muenchener Rueckversicher Stock
Muenchener Rueckversicher
SupplierCustomer0,870,420,420,090,300,36
1

Most common questions regarding SHL Telemedicine

What values and corporate philosophy does SHL Telemedicine represent?

SHL Telemedicine Ltd represents values of innovation, excellence, and patient-centric care. As a leading provider of telemedicine solutions, SHL prioritizes technological advancements to revolutionize healthcare access and delivery. Their corporate philosophy emphasizes the importance of improving medical outcomes and patient experience through virtual medical services. By leveraging advanced telecommunication technologies, SHL Telemedicine Ltd aims to bridge the gap between patients and healthcare professionals, ensuring convenient and timely healthcare services. With a focus on patient-centric care, SHL strives to improve the quality and accessibility of healthcare for individuals worldwide.

In which countries and regions is SHL Telemedicine primarily present?

SHL Telemedicine Ltd is primarily present in various countries and regions. This global telemedicine company has a significant presence in Israel, where it was originally founded. Additionally, SHL Telemedicine Ltd extends its operations to other parts of the world, including Europe, North America, Asia, and Latin America. With its international footprint, the company aims to provide innovative telemedicine services and solutions across different geographic locations.

What significant milestones has the company SHL Telemedicine achieved?

SHL Telemedicine Ltd has achieved several significant milestones in its journey. The company has emerged as a leader in the telemedicine industry, offering innovative and high-quality healthcare solutions. SHL Telemedicine Ltd has successfully expanded its global footprint, establishing a strong presence in various regions. Moreover, the company has gained recognition for its cutting-edge technology and continuous commitment to patient care. Through strategic partnerships and collaborations, SHL Telemedicine Ltd has further strengthened its position in the market, ensuring enhanced accessibility to telemedical services. With its unwavering dedication to excellence, SHL Telemedicine Ltd continues to revolutionize the way healthcare is delivered, setting new benchmarks and improving patient outcomes.

What is the history and background of the company SHL Telemedicine?

SHL Telemedicine Ltd is a renowned telemedicine company that has a rich history and background. Founded in 1987, SHL Telemedicine has been a pioneer in the telehealth industry, providing innovative and reliable healthcare solutions globally. The company specializes in developing and manufacturing advanced medical devices and digital health platforms for remote patient monitoring and diagnosis. With a strong focus on improving healthcare accessibility and patient outcomes, SHL Telemedicine has established itself as a trusted provider of telemedicine services worldwide. Continuously evolving and adapting to the changing healthcare landscape, the company has garnered an excellent reputation for its cutting-edge technology and commitment to quality patient care.

Who are the main competitors of SHL Telemedicine in the market?

SHL Telemedicine Ltd faces competition from various players in the market. Some of its main competitors include companies like Teladoc Health Inc., Amwell, Doctor On Demand, and Medici. These competitors also operate in the telemedicine sector and offer similar services such as virtual doctor consultations and remote patient monitoring. Despite the market competition, SHL Telemedicine Ltd strives to differentiate itself through its advanced technology, strong market presence, and its focus on delivering high-quality healthcare solutions to its customers.

In which industries is SHL Telemedicine primarily active?

SHL Telemedicine Ltd is primarily active in the healthcare and telemedicine industry.

What is the business model of SHL Telemedicine?

The business model of SHL Telemedicine Ltd focuses on providing remote healthcare solutions worldwide. As a leading telemedicine company, SHL Telemedicine offers a range of products and services for medical professionals and patients. Their telemedicine platform enables virtual consultations, remote monitoring, and medical data management. By leveraging technology and connectivity, SHL Telemedicine aims to bridge the gap between patients and healthcare providers, improving access to quality healthcare and reducing the need for physical visits. With their innovative solutions, SHL Telemedicine facilitates convenient and efficient healthcare delivery, enhancing patient outcomes and optimizing healthcare resources.

What is the P/E ratio of SHL Telemedicine 2024?

The P/E ratio cannot be calculated for SHL Telemedicine at the moment.

What is the P/S ratio of SHL Telemedicine 2024?

The P/S cannot be calculated for SHL Telemedicine currently.

What is the Quality Investing of SHL Telemedicine?

The Quality Investing for SHL Telemedicine is 4/10.

What is the revenue of SHL Telemedicine 2024?

The revenue cannot currently be calculated for SHL Telemedicine.

How high is the profit of SHL Telemedicine 2024?

The profit cannot currently be calculated for SHL Telemedicine.

What is the business model of SHL Telemedicine

SHL Telemedicine Ltd is a company specializing in providing telemedicine and remote monitoring solutions. The company was founded in 1987 and is headquartered in Israel. With over 30 years of experience in the field of telemedicine, SHL Telemedicine Ltd has built a solid reputation and operates in over 50 countries worldwide. The company is divided into three different business areas: cardiology, sleep medicine, and remote monitoring. Each of these areas offers a range of products and services tailored to the specific needs and requirements of patients and medical professionals. The cardiology division offers a wide range of products and services focused on the diagnosis and treatment of cardiovascular diseases. This includes EKG systems, long-term EKG recording devices, and monitoring devices for measuring blood pressure and blood oxygen saturation. The company has also developed a platform for remote monitoring of patients with heart failure, allowing medical professionals to monitor their patients' health in real-time and respond quickly if needed. In the field of sleep medicine, the company offers a wide range of products and services focused on the diagnosis and treatment of sleep disorders. This includes measuring devices for monitoring breathing, blood pressure, and heart rate during sleep. The company has also developed a revolutionary remote monitoring platform that allows medical professionals to monitor and treat sleep disorders in real-time. In the field of remote monitoring, SHL Telemedicine Ltd offers a platform that allows medical professionals to monitor and treat patients in real-time. The platform can be used to monitor patients with chronic conditions such as heart failure, diabetes, and COPD. The platform also allows for remote monitoring of patients who are in the hospital or have just been discharged. Overall, SHL Telemedicine Ltd is a leading provider of telemedicine and remote monitoring solutions. The company offers a wide range of products and services tailored to the specific needs and requirements of medical professionals and patients. With its extensive experience and expertise in telemedicine, SHL Telemedicine Ltd has built a solid reputation and operates in over 50 countries worldwide.

What is the SHL Telemedicine dividend?

SHL Telemedicine pays a dividend of 0 USD distributed over payouts per year.

How often does SHL Telemedicine pay dividends?

The dividend cannot currently be calculated for SHL Telemedicine or the company does not pay out a dividend.

What is the SHL Telemedicine ISIN?

The ISIN of SHL Telemedicine is IL0010855885.

What is the SHL Telemedicine WKN?

The WKN of SHL Telemedicine is 589969.

What is the SHL Telemedicine ticker?

The ticker of SHL Telemedicine is SHLTN.SW.

How much dividend does SHL Telemedicine pay?

Over the past 12 months, SHL Telemedicine paid a dividend of 1 USD . This corresponds to a dividend yield of about 37.65 %. For the coming 12 months, SHL Telemedicine is expected to pay a dividend of 0 USD.

What is the dividend yield of SHL Telemedicine?

The current dividend yield of SHL Telemedicine is 37.65 %.

When does SHL Telemedicine pay dividends?

SHL Telemedicine pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SHL Telemedicine?

SHL Telemedicine paid dividends every year for the past 0 years.

What is the dividend of SHL Telemedicine?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is SHL Telemedicine located?

SHL Telemedicine is assigned to the 'Health' sector.

Wann musste ich die Aktien von SHL Telemedicine kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SHL Telemedicine from 4/16/2019 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 4/10/2019.

When did SHL Telemedicine pay the last dividend?

The last dividend was paid out on 4/16/2019.

What was the dividend of SHL Telemedicine in the year 2023?

In the year 2023, SHL Telemedicine distributed 0 USD as dividends.

In which currency does SHL Telemedicine pay out the dividend?

The dividends of SHL Telemedicine are distributed in USD.

All fundamentals about SHL Telemedicine

Our stock analysis for SHL Telemedicine Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SHL Telemedicine Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.